ETF Holdings Breakdown of REPL

Stock NameReplimune Group Inc
TickerREPL(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS76029N1063
LEI549300AY704NEIRC4K64

News associated with REPL

Exchange Traded Concepts LLC Sells 5,196 Shares of Replimune Group, Inc. (NASDAQ:REPL)
Exchange Traded Concepts LLC trimmed its stake in Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 32.5% in the first quarter, HoldingsChannel.com reports. The firm owned 10,814 shares of the company’s stock after selling 5,196 shares during the period. Exchange Traded Concepts LLC’s holdings in Replimune Group were worth $105,000 at the end of the […] - 2025-06-25 07:57:01
California State Teachers Retirement System Raises Stake in Replimune Group, Inc. (NASDAQ:REPL)
California State Teachers Retirement System boosted its position in Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 25.9% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 42,725 shares of the company’s stock after purchasing an additional 8,793 shares during the period. California State Teachers Retirement System’s holdings in Replimune Group were worth […] - 2025-06-12 07:52:49
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $796,000 Stake in Replimune Group, Inc. (NASDAQ:REPL)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC trimmed its stake in Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 19.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 65,762 shares of the company’s stock after selling 15,402 […] - 2025-06-11 07:38:55
Replimune Group, Inc. (NASDAQ:REPL) Receives $19.43 Consensus PT from Analysts
Replimune Group, Inc. (NASDAQ:REPL – Get Free Report) has earned an average rating of “Buy” from the nine analysts that are presently covering the company, Marketbeat reports. Eight research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 12 month target price […] - 2025-06-03 06:07:12
Two Sigma Investments LP Buys 33,346 Shares of Replimune Group, Inc. (NASDAQ:REPL)
Two Sigma Investments LP boosted its stake in shares of Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 18.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 212,586 shares of the company’s stock after acquiring an additional 33,346 shares during […] - 2025-06-01 09:37:00
Replimune Group, Inc. (NASDAQ:REPL) Stock Position Lifted by ProShare Advisors LLC
ProShare Advisors LLC grew its position in shares of Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 33.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 20,788 shares of the company’s stock after buying an additional 5,247 shares during the […] - 2025-06-01 08:46:47
Thursday's ETF Movers: XBI, URA
In trading on Thursday, the SPDR S&P Biotech ETF is outperforming other ETFs, up about 1.9% on the day. Components of that ETF showing particular strength include shares of Oric Pharmaceuticals, up about 33.8% and shares of Replimune Group, up about 9.6% on the day. And un - 2025-05-29 15:59:01
Two Sigma Advisers LP Lowers Position in Replimune Group, Inc. (NASDAQ:REPL)
Two Sigma Advisers LP decreased its position in shares of Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 9.6% during the fourth quarter, Holdings Channel reports. The fund owned 170,400 shares of the company’s stock after selling 18,000 shares during the period. Two Sigma Advisers LP’s holdings in Replimune Group were worth $2,064,000 as of […] - 2025-05-29 08:52:49
Nuveen Asset Management LLC Boosts Stake in Replimune Group, Inc. (NASDAQ:REPL)
Nuveen Asset Management LLC lifted its stake in Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 108.9% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 667,634 shares of the company’s stock after purchasing an additional 347,993 shares during the period. Nuveen Asset […] - 2025-05-29 07:56:55
Quantinno Capital Management LP Invests $127,000 in Replimune Group, Inc. (NASDAQ:REPL)
Quantinno Capital Management LP acquired a new stake in shares of Replimune Group, Inc. (NASDAQ:REPL – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 10,455 shares of the company’s stock, valued at approximately $127,000. Other institutional investors and […] - 2025-05-28 08:08:55
Investors Buy High Volume of Replimune Group Call Options (NASDAQ:REPL)
Replimune Group, Inc. (NASDAQ:REPL – Get Free Report) saw some unusual options trading on Thursday. Traders acquired 5,508 call options on the stock. This is an increase of approximately 652% compared to the average volume of 732 call options. Insider Buying and Selling at Replimune Group In other Replimune Group news, CAO Andrew Schwendenman sold […] - 2025-05-23 05:01:01
Hsbc Holdings PLC Buys Shares of 14,008 Replimune Group, Inc. (NASDAQ:REPL)
Hsbc Holdings PLC purchased a new position in Replimune Group, Inc. (NASDAQ:REPL – Free Report) during the 4th quarter, HoldingsChannel reports. The firm purchased 14,008 shares of the company’s stock, valued at approximately $175,000. Several other hedge funds also recently modified their holdings of the business. Sterling Capital Management LLC increased its position in Replimune […] - 2025-05-12 07:56:47
Barclays PLC Raises Stock Holdings in Replimune Group, Inc. (NASDAQ:REPL)
Barclays PLC boosted its holdings in shares of Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 5.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 167,329 shares of the company’s stock after acquiring an additional 8,838 shares during the quarter. […] - 2025-05-02 09:03:01
Invesco Ltd. Trims Stock Position in Replimune Group, Inc. (NASDAQ:REPL)
Invesco Ltd. cut its holdings in Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 51.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 88,006 shares of the company’s stock after selling 92,952 shares during the period. Invesco Ltd.’s holdings in Replimune Group were worth $1,066,000 […] - 2025-05-02 07:30:49
Replimune Group, Inc. (NASDAQ:REPL) Shares Acquired by Wells Fargo & Company MN
Wells Fargo & Company MN boosted its holdings in Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 102.3% in the fourth quarter, HoldingsChannel.com reports. The firm owned 77,371 shares of the company’s stock after acquiring an additional 39,121 shares during the period. Wells Fargo & Company MN’s holdings in Replimune Group were worth $937,000 as […] - 2025-04-30 08:14:51
Legal & General Group Plc Acquires 17,597 Shares of Replimune Group, Inc. (NASDAQ:REPL)
Legal & General Group Plc lifted its holdings in shares of Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 42.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 59,366 shares of the company’s stock after purchasing an additional 17,597 shares during the […] - 2025-04-29 07:50:50
Analysts Set Replimune Group, Inc. (NASDAQ:REPL) Target Price at $19.43
Replimune Group, Inc. (NASDAQ:REPL – Get Free Report) has been given an average rating of “Buy” by the eight brokerages that are presently covering the company, Marketbeat Ratings reports. Seven analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month price target […] - 2025-04-14 05:59:04
Corebridge Financial Inc. Sells 2,284 Shares of Replimune Group, Inc. (NASDAQ:REPL)
Corebridge Financial Inc. trimmed its holdings in Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 7.0% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 30,267 shares of the company’s stock after selling 2,284 shares during the period. Corebridge Financial Inc.’s holdings in Replimune Group were worth $367,000 at the end of the most […] - 2025-04-10 08:33:06

REPL institutional holdings

The following institutional investment holdings of REPL have been identified

Date ETF ISIN/Name Num Shares Book value
2025-06-26 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 36,325USD 343,635
2025-06-26 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 9,487USD 89,747
2025-06-26 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 38,200USD 361,372
2025-06-26 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 38,200USD 361,372
2025-06-26 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 395USD 3,737
Total =122,607 USD 1,159,863
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.